PURA VIDA INVESTMENTS, LLC Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001590144
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2024 · 46 positions · Total reported value $146.69M · Top-10 concentration 54.9% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 31.6% · 2 new · 4 cut · 0 exited
Active Share (vs S&P 500): 92.7% · vs QQQ: 92.7% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): +36.5% · vs SPY +21.7% · Prev Value $14.88M — last quarter positions weighted by this quarter price moves · ranking
In its Q2 2024 13F filing, PURA VIDA INVESTMENTS, LLC disclosed 46 equity positions with a combined reported value of $146.69M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 54.9% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.
The largest disclosed positions as of Q2 2024 were SPY ($13.61M), ESTA ($10.46M), GKOS ($10.30M). By sector, the heaviest allocations are Health Care 56.6%, Industrials 6.4%. Versus the prior quarter, allocation shifted toward Industrials (+3.1pp) and away from Health Care (-1.2pp), Other (-1.9pp).
Versus the prior quarter, PURA VIDA INVESTMENTS, LLC opened 2 new positions, trimmed 4 and fully exited 0, a turnover rate of 31.6% of positions. The portfolio's overlap with the prior quarter was 39% of names.
The largest new positions opened in Q2 2024 were ACWX ($5.04M), XITK ($4.64M), IXP ($4.06M).
Of the 8 positions fully exited versus the prior quarter, the largest were HUM ($60.68M), HSCS ($34.19M), EXAS ($33.28M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2024)
- ACWX ISHARES TR · $5.04M
- XITK SPDR SERIES TRUST · $4.64M
- IXP ISHARES TR · $4.06M
- ICUI ICU MED INC · $3.48M
- CSTL CASTLE BIOSCIENCES INC · $3.34M
- MASI MASIMO CORP · $3.15M
- ARKG ARK ETF TR · $2.70M
- COO COOPER COS INC · $2.62M
Fully Exited (vs previous quarter)
- HUM HUMANA INC · prev qtr: $60.68M
- HSCS HEARTSCIENCES INC · prev qtr: $34.19M
- EXAS EXACT SCIENCES CORP · prev qtr: $33.28M
- LYRA LYRA THERAPEUTICS INC · prev qtr: $8.79M
- BHC BAUSCH HEALTH COS INC · prev qtr: $4.24M
- DXCM DEXCOM INC · prev qtr: $4.16M
- VKTX VIKING THERAPEUTICS INC · prev qtr: $3.27M
- SWAV SHOCKWAVE MED INC · prev qtr: $2.86M
Insider Transactions (Form 4)
Latest PURA VIDA INVESTMENTS, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Pura Vida Investments, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 19 positions worth $36.99M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-80547 (status: Approved), registered 2014-12-15
- Regulatory AUM (Form ADV): $91.46M as of 2026-03-30
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 3 private funds, of which 2 hedge funds
- Website: puravidainvestments.com
Portfolio Structure
- 19 positions · $36.99M reported value (Q2 2026)
- Top 10 holdings = 92.4% of reported value
- Largest position: ALMR (ALAMAR BIOSCIENCES INC) at 55.4%
- Average position size: $1.95M
Sector Tilt
- Industrials 55.4%
- Health Care 35.1%
- Information Technology 6.4%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 2 new, 2 added, 4 reduced
- 11 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
25.00K | $13.61M | 9.28% | Reduce | |
| 2 |
|
230.09K | $10.46M | 7.13% | Reduce | |
| 3 |
|
87.00K | $10.30M | 7.02% | Add | |
| 4 |
|
20.00K | $9.58M | 6.53% | Reduce | |
| 5 |
|
18.90K | $8.41M | 5.73% | Add | |
| 6 |
|
67.50K | $7.31M | 4.98% | Reduce | |
| 7 |
|
787.00K | $5.77M | 3.93% | Add | |
| 8 |
|
409.33K | $5.41M | 3.69% | Add | |
| 9 |
|
90.00K | $5.04M | 3.44% | New | |
| 10 |
|
50.00K | $4.64M | 3.16% | New | |
| 11 |
|
24.00K | $4.59M | 3.13% | Reduce | |
| 12 |
|
20.00K | $4.06M | 2.77% | New | |
| 13 |
|
30.00K | $4.01M | 2.74% | Add | |
| 14 |
|
29.33K | $3.48M | 2.38% | New | |
| 15 |
|
153.39K | $3.34M | 2.28% | New | |
| 16 |
|
512.96K | $3.25M | 2.22% | Add | |
| 17 |
|
25.00K | $3.15M | 2.15% | New | |
| 18 |
|
100.00K | $2.89M | 1.97% | Hold | |
| 19 |
|
115.00K | $2.70M | 1.84% | New | |
| 20 |
|
30.00K | $2.62M | 1.78% | New | |
| 21 |
|
46.70K | $2.56M | 1.75% | Reduce | |
| 22 |
|
30.00K | $2.36M | 1.61% | New | |
| 23 |
|
50.00K | $2.20M | 1.50% | New | |
| 24 |
|
199.00K | $2.08M | 1.42% | Reduce | |
| 25 |
|
32.50K | $2.07M | 1.41% | New | |
| 26 |
|
7.50K | $1.87M | 1.28% | New | |
| 27 |
|
1.17M | $1.76M | 1.20% | Add | |
| 28 |
|
40.50K | $1.63M | 1.11% | Reduce | |
| 29 |
|
280.00K | $1.61M | 1.10% | New | |
| 30 |
|
495.35K | $1.46M | 1.00% | Reduce | |
| 31 |
|
30.00K | $1.43M | 0.97% | New | |
| 32 |
|
70.00K | $1.28M | 0.87% | Reduce | |
| 33 |
|
450.52K | $1.12M | 0.77% | Hold | |
| 34 |
|
21.00K | $1.11M | 0.76% | New | |
| 35 |
|
5.00K | $1.10M | 0.75% | New | |
| 36 |
|
60.00K | $1.09M | 0.75% | Reduce | |
| 37 |
|
6.00K | $1.08M | 0.74% | New | |
| 38 |
|
270.62K | $1.04M | 0.71% | Reduce | |
| 39 |
|
56.60K | $816.78K | 0.56% | Reduce | |
| 40 |
|
10.00K | $779.20K | 0.53% | New | |
| 41 |
|
10.00K | $492.80K | 0.34% | New | |
| 42 |
|
10.00K | $481.50K | 0.33% | New | |
| 43 |
|
8.00K | $361.60K | 0.25% | New | |
| 44 |
|
10.00K | $261.40K | 0.18% | New | |
| 45 |
|
238.50K | $23.85K | 0.02% | Reduce | |
| 46 |
|
50.00K | $2.52K | 0.00% | Hold | |
FAQ
What did PURA VIDA INVESTMENTS, LLC buy in 2024-Q2?
In its 2024-Q2 13F filing, PURA VIDA INVESTMENTS, LLC reported 46 equity positions worth $146.69M in aggregate; its largest disclosed positions were SPY ($13.61M), ESTA ($10.46M), GKOS ($10.30M).
How large is PURA VIDA INVESTMENTS, LLC's portfolio?
PURA VIDA INVESTMENTS, LLC reported $146.69M of long equity holdings across 46 positions as of 2024-Q2. Top-10 holdings account for 54.9% of reported value.
What is PURA VIDA INVESTMENTS, LLC's investment style?
HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.